Advances in Research on COVID-19 Vaccination for People Living with HIV.
作者信息
Jin Junyan, Wang Xiuwen, Carapito Raphael, Moog Christiane, Su Bin
机构信息
Beijing Key Laboratory for HIV/AIDS Research, Sino-French Joint Laboratory for Research on Humoral Immune Response to HIV Infection, Clinical and Research Center for Infectious Diseases, Beijing Youan Hospital, Capital Medical University, Beijing 100069, China.
Laboratoire d'ImmunoRhumatologie Moléculaire, Institut National de la Santé et de la Recherche Médicale (INSERM) UMR_S 1109, Institut Thématique Interdisciplinaire (ITI) de Médecine de Précision de Strasbourg, Transplantex NG, Faculté de Médecine, Fédération Hospitalo-Universitaire OMICARE, Fédération de Médecine Translationnelle de Strasbourg (FMTS), Université de Strasbourg, Strasbourg 67000, France.
出版信息
Infect Dis Immun. 2022 Oct;2(4):213-218. doi: 10.1097/ID9.0000000000000065. Epub 2022 Sep 1.
Abstract
摘要
相似文献
1
Advances in Research on COVID-19 Vaccination for People Living with HIV.针对艾滋病毒感染者的新冠疫苗接种研究进展
Infect Dis Immun. 2022 Oct;2(4):213-218. doi: 10.1097/ID9.0000000000000065. Epub 2022 Sep 1.
2
SARS-CoV-2 Vaccination Coverage and Factors Associated with Low Uptake in a Cohort of People Living with HIV.严重急性呼吸综合征冠状病毒2型（SARS-CoV-2）疫苗接种覆盖率及与一组艾滋病毒感染者接种率低相关的因素
Microorganisms. 2022 Aug 18;10(8):1666. doi: 10.3390/microorganisms10081666.
3
Humoral immune response in people living with HIV after administration of SARS-CoV-2 vaccine CoronaVac or BNT162b2 or CoronaVac/BNT162b2 booster sequence: A cross-sectional study.接种科兴或辉瑞疫苗加强针后，HIV 感染者的体液免疫反应：一项横断面研究。
Vaccine. 2024 Jan 25;42(3):671-676. doi: 10.1016/j.vaccine.2023.12.035. Epub 2023 Dec 20.
4
Despite delayed kinetics, people living with HIV achieve equivalent antibody function after SARS-CoV-2 infection or vaccination.尽管存在延迟的动力学，但感染 SARS-CoV-2 或接种疫苗后，HIV 感染者也能获得等效的抗体功能。
Front Immunol. 2023 Aug 3;14:1231276. doi: 10.3389/fimmu.2023.1231276. eCollection 2023.
5
Are people living with HIV have a low vulnerability to omicron variant infection: results from a cross-sectional study in China.HIV 感染者对奥密克戎变异株感染的脆弱性较低：来自中国的横断面研究结果。
BMC Infect Dis. 2023 Nov 14;23(1):795. doi: 10.1186/s12879-023-08768-x.
6
Severe immunosuppression is related to poorer immunogenicity to SARS-CoV-2 vaccines among people living with HIV.严重的免疫抑制与艾滋病毒感染者对 SARS-CoV-2 疫苗的免疫原性较差有关。
Clin Microbiol Infect. 2022 Nov;28(11):1492-1498. doi: 10.1016/j.cmi.2022.05.018. Epub 2022 May 28.
7
COVID-19 Vaccination Willingness Among People Living With HIV in Wuhan, China.中国武汉 HIV 感染者的 COVID-19 疫苗接种意愿。
Front Public Health. 2022 May 9;10:883453. doi: 10.3389/fpubh.2022.883453. eCollection 2022.
8
COVID-19 Outcomes and Risk Factors Among People Living with HIV.COVID-19 结局和 HIV 感染者的危险因素。
Curr HIV/AIDS Rep. 2022 Oct;19(5):425-432. doi: 10.1007/s11904-022-00618-w. Epub 2022 Aug 5.
9
Extending the dosing interval of COVID-19 vaccination leads to higher rates of seroconversion in people living with HIV.延长 COVID-19 疫苗接种间隔时间可提高 HIV 感染者的血清转化率。
Front Immunol. 2023 Mar 2;14:1152695. doi: 10.3389/fimmu.2023.1152695. eCollection 2023.
10
Effect of SARS-CoV-2 Breakthrough Infection on HIV Reservoirs and T-Cell Immune Recovery in 3-Dose Vaccinated People Living with HIV.SARS-CoV-2 突破感染对 3 剂疫苗接种的 HIV 感染者中 HIV 储存库和 T 细胞免疫恢复的影响。
Viruses. 2023 Dec 14;15(12):2427. doi: 10.3390/v15122427.
引用本文的文献
1
Dynamic SARS-CoV-2-specific B-cell and T-cell responses induced in people living with HIV after a full course of inactivated SARS-CoV-2 vaccine.在接受完整疗程的灭活新型冠状病毒疫苗接种后，HIV感染者体内诱导产生的动态新型冠状病毒特异性B细胞和T细胞反应。
Front Immunol. 2025 Feb 25;16:1554409. doi: 10.3389/fimmu.2025.1554409. eCollection 2025.
2
Severe acute respiratory syndrome coronavirus 2-specific T-cell responses are induced in people living with human immunodeficiency virus after booster vaccination.在接受加强疫苗接种后，人类免疫缺陷病毒感染者体内可诱导出针对严重急性呼吸综合征冠状病毒2的特异性T细胞反应。
Chin Med J (Engl). 2024 Nov 20;137(22):2734-2744. doi: 10.1097/CM9.0000000000003176. Epub 2024 Jul 18.
3
Association between SARS-CoV-2 RNAemia, skewed T cell responses, inflammation, and severity in hospitalized COVID-19 people living with HIV.住院的合并感染新型冠状病毒的艾滋病毒感染者中，严重急性呼吸综合征冠状病毒2型病毒血症、T细胞反应失衡、炎症与疾病严重程度之间的关联。
iScience. 2023 Dec 7;27(1):108673. doi: 10.1016/j.isci.2023.108673. eCollection 2024 Jan 19.
本文引用的文献
1
Diagnosis and Treatment Protocol for COVID-19 Patients (Tentative 8th Edition).新型冠状病毒肺炎诊疗方案（试行第八版）
Infect Dis Immun. 2021 Apr 20;1(1):8-16. doi: 10.1097/01.ID9.0000733564.21786.b0. eCollection 2021 Apr.
2
Vaccine effectiveness of one, two, and three doses of BNT162b2 and CoronaVac against COVID-19 in Hong Kong: a population-based observational study.BNT162b2 和科兴疫苗一剂、两剂和三剂对香港 COVID-19 的疫苗有效性：基于人群的观察性研究。
Lancet Infect Dis. 2022 Oct;22(10):1435-1443. doi: 10.1016/S1473-3099(22)00345-0. Epub 2022 Jul 15.
3
Immune response and safety to inactivated COVID-19 vaccine: a comparison between people living with HIV and HIV-naive individuals.免疫应答和安全性：感染 HIV 人群与 HIV 阴性人群接种新冠灭活疫苗的比较
AIDS Res Ther. 2022 Jul 5;19(1):33. doi: 10.1186/s12981-022-00459-y.
4
Heterologous immunization with inactivated vaccine followed by mRNA-booster elicits strong immunity against SARS-CoV-2 Omicron variant.异源接种灭活疫苗后再接种 mRNA 加强针可诱导针对 SARS-CoV-2 奥密克戎变异株的强烈免疫应答。
Nat Commun. 2022 May 13;13(1):2670. doi: 10.1038/s41467-022-30340-5.
5
T-cell responses to SARS-CoV-2 Omicron spike epitopes with mutations after the third booster dose of an inactivated vaccine.接种灭活疫苗第三针加强针后发生突变的奥密克戎刺突表位的 T 细胞反应。
J Med Virol. 2022 Aug;94(8):3998-4004. doi: 10.1002/jmv.27814. Epub 2022 May 6.
6
Comparative Effectiveness of mRNA and Inactivated Whole-Virus Vaccines Against Coronavirus Disease 2019 Infection and Severe Disease in Singapore.新加坡 2019 年冠状病毒病感染和重症的 mRNA 疫苗和全病毒灭活疫苗的疗效比较。
Clin Infect Dis. 2022 Oct 12;75(8):1442-1445. doi: 10.1093/cid/ciac288.
7
Safety and immunogenicity of inactivated SARS-CoV-2 vaccines in people living with HIV.在 HIV 感染者中使用灭活 SARS-CoV-2 疫苗的安全性和免疫原性。
Emerg Microbes Infect. 2022 Dec;11(1):1126-1134. doi: 10.1080/22221751.2022.2059401.
8
Humoral and Cellular Immune Response Elicited by mRNA Vaccination Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in People Living With Human Immunodeficiency Virus Receiving Antiretroviral Therapy Based on Current CD4 T-Lymphocyte Count.基于当前CD4 T淋巴细胞计数，在接受抗逆转录病毒治疗的人类免疫缺陷病毒感染者中，mRNA疫苗接种针对严重急性呼吸综合征冠状病毒2（SARS-CoV-2）引发的体液和细胞免疫反应
Clin Infect Dis. 2022 Aug 24;75(1):e552-e563. doi: 10.1093/cid/ciac238.
9
SARS-CoV-2 Humoral and Cellular Immune Responses of Patients With HIV After Vaccination With BNT162b2 mRNA COVID-19 Vaccine in the Tel-Aviv Medical Center.特拉维夫医疗中心接受BNT162b2 mRNA新冠疫苗接种的HIV患者的SARS-CoV-2体液和细胞免疫反应
Open Forum Infect Dis. 2022 Feb 23;9(4):ofac089. doi: 10.1093/ofid/ofac089. eCollection 2022 Apr.
10
Safety and immunogenicity of CoronaVac in people living with HIV: a prospective cohort study.科兴新冠疫苗在 HIV 感染者中的安全性和免疫原性：一项前瞻性队列研究。
Lancet HIV. 2022 May;9(5):e323-e331. doi: 10.1016/S2352-3018(22)00033-9. Epub 2022 Mar 23.
Zotero 插件